3 assets in Polyneuropathy

Therapeutic assets addressing Polyneuropathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Acoramidis Polyneuropathy	Eidos Therapeutics, a BridgeBio company	P3	B (60)
Nexiguran Ziclumeran Polyneuropathy	Intellia Therapeutics	P3	B (60)
Patisiran Polyneuropathy	Austin Neuromuscular Center	Early P1	CC (43)